Thursday, 15 October 2026European Markets

TELENOR And KINEPOLIS GROUP Have A High Dividend Yield And Return On Equity In The Communication Services Sector.

Loading stream...

(VIANEWS) - TELENOR (TEL.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Communication Services sector.

Financial Asset Price Forward Dividend Yield Return on Equity
TELENOR (TEL.OL) kr133.80 6.67% 14.47%
KINEPOLIS GROUP (KIN.BR) €39.60 1.38% 20.21%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. TELENOR (TEL.OL)

6.67% Forward Dividend Yield and 14.47% Return On Equity

Telenor ASA, together with its subsidiaries, operates as a telecommunication company worldwide. It operates through four segments: Nordics, Asia, Infrastructure, and Amp. The company offers mobile subscriptions and handsets, telephony, broadband, data security, communications services, and TV services to residential and business customers, as well as wholesale services. It also builds, develops, maintains, and leases passive telecom infrastructure, such as towers, masts, and buildings. The company also provides machine-to-machine, internet-of-things, and inbound and national roaming services. Telenor ASA was founded in 1855 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, TELENOR has a trailing twelve months EPS of kr6.6.

PE Ratio

TELENOR has a trailing twelve months price to earnings ratio of 20.27. Meaning, the purchaser of the share is investing kr20.27 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.47%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.4%, now sitting on 80.43B for the twelve trailing months.

Moving Average

TELENOR's value is higher than its 50-day moving average of kr129.87 and higher than its 200-day moving average of kr123.07.

Volatility

TELENOR's last week, last month's, and last quarter's current intraday variation average was a negative 0.40%, a negative 0.04%, and a positive 0.70%.

TELENOR's highest amplitude of average volatility was 0.54% (last week), 0.66% (last month), and 0.70% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TELENOR's stock is considered to be overbought (>=80).

More news about TELENOR.

2. KINEPOLIS GROUP (KIN.BR)

1.38% Forward Dividend Yield and 20.21% Return On Equity

Kinepolis Group NV operates cinema complexes in Belgium, the Netherlands, France, Spain, Luxembourg, Switzerland, Poland, Canada, and the United States. The company operates cinema complexes under the KINEPOLIS, Landmark Cinemas, and MJR THEATRES brands. It also organizes company events; sells vouchers to companies and publicity campaigns in the cinema; and beverages and snacks in the cinema complexes, as well as operates the self-service shop and other in-theatre sales concepts. It is also involved in distribution of movies, as well as alternative content, such as concerts, kids content, etc.; production and promotion of Flemish films; screen advertising; and rental of real estate. Kinepolis Group NV was incorporated in 1976 and is based in Brussels, Belgium.

Earnings Per Share

As for profitability, KINEPOLIS GROUP has a trailing twelve months EPS of €2.03.

PE Ratio

KINEPOLIS GROUP has a trailing twelve months price to earnings ratio of 19.51. Meaning, the purchaser of the share is investing €19.51 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.21%.

Volume

Today's last reported volume for KINEPOLIS GROUP is 7862 which is 58.22% below its average volume of 18818.

More news about KINEPOLIS GROUP.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com